好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2004 Annual Meeting | Multiple Sclerosis: Outcomes

Wednesday 04/28/04
04:00 PM - 05:15 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Platform Session
MS and Related Diseases
No CME available
Event Timeline
04:00 PM - 05:15 PM Abstract 001 - Boosting Regulatory T Cells with T Cell Receptor Peptides: A Tripeptide Vaccine in Incomplete Freund's Adjuvant Is Highly Immunongenic in Multiple Sclerosis Patients
04:00 PM - 05:15 PM Abstract 002 - Sample Size Calculations for a Parallel Groups, Placebo Controlled Treatment Trial in Secondary Progressive Multiple Sclerosis Using Cerebral Atrophy as the Primary Outcome Measure
04:00 PM - 05:15 PM Abstract 003 - The Outcome of Optic Neuritis after 30 Years of Follow Up
04:00 PM - 05:15 PM Abstract 004 - Decreased Cardiovascular Disease but Increased Stroke in Patients with Multiple Sclerosis
04:00 PM - 05:15 PM Abstract 005 - The Impact of Immunoablation with Autologous Stem Cell Transplant on Lesion Remyelination and Demyelination in Aggressive Multiple Sclerosis
Faculty Disclosures
Tanuja Chitnis, MD, FAAN Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Siemens. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Biosciences. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. The institution of Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Academic CME. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche. The institution of Dr. Chitnis has received research support from Tiziana Life Sciences. The institution of Dr. Chitnis has received research support from Bristol-Myers Squibb. The institution of Dr. Chitnis has received research support from Wesley Clover.
Amit Bar-Or, MD, FRCPC Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merk/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for cabaletta. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. The institution of Dr. Bar-Or has received research support from Novartis. The institution of Dr. Bar-Or has received research support from Biogen. The institution of Dr. Bar-Or has received research support from Roche/Genentech.
Madhuri Behari, MD No disclosure on file
Fazeel M. Siddiqui, MD No disclosure on file
Jeffrey C. Wagner, MD Dr. Wagner has nothing to disclose.
Deepti Vibha, MD Dr. Vibha has nothing to disclose.
Mario Emilio Dourado Junior, Jr. No disclosure on file
No disclosure on file
Ahmad El Kouzi, MD, FAAN Dr. El Kouzi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie.
David Bar-Or David Bar-Or has received intellectual property interests from a discovery or technology relating to health care.
Michelle Whaley No disclosure on file
Pedro Fraiman, MD Dr. Fraiman has a non-compensated relationship as a Neurology Resident & Fellow Section Editorial Board Member with Neurology Journal that is relevant to AAN interests or activities.
Maria C. Rodriquez No disclosure on file
Hui Yang, PhD No disclosure on file
Jacob Yomtoob, MD Dr. Yomtoob has nothing to disclose.
Nikita Shukla, MD The institution of Dr. Shukla has received research support from Roche.
Yi-Chen Lai No disclosure on file
Jamila Godil No disclosure on file